Clinical Trial Update: Clinical Study the Efficacy and Safety of Rh-EPO in the Treatment of Anemia in Lymphoma [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the efficacy and safety of recombinant human erythropoietin (Rh-EPO) for anemia associated with lymphoma is described, with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Lymphoma

Drugs mentioned

• Rh-EPO (recombinant human erythropoietin)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Lymphoma, Anemia | Phase 3 | Status: UNKNOWN